Pooled analysis of the performance of liquid‐based cytology in population‐based cervical cancer screening studies in China
Open Access
- 23 April 2013
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 121 (9), 473-482
- https://doi.org/10.1002/cncy.21297
Abstract
BACKGROUND Liquid‐based cytology (LBC) has been widely used for cervical cancer screening. Despite numerous studies and systematic reviews, to the authors' knowledge few large studies to date have focused on biopsy‐confirmed cervical lesions and controversy remains concerning its diagnostic accuracy. The objective of the current study was to assess LBC for detecting biopsy‐confirmed cervical intraepithelial neoplasia (CIN) and cancer. METHODS A pooled analysis of LBC using data from 13 population‐based, cross‐sectional, cervical cancer screening studies performed in China from 1999 to 2008 was performed. Participants (n = 26,782) received LBC and human papillomavirus testing. Women found to be positive on screening were referred for colposcopy and biopsy. The accuracy of LBC for detecting biopsy‐confirmed CIN of type 2 or worse (CIN2+) as well as CIN type 3 or worse (CIN3+) lesions was analyzed. RESULTS Of 25,830 women included in the analysis, CIN2+ was found in 107 of 2612 with atypical squamous cells (4.1%), 142 of 923 with low‐grade squamous intraepithelial neoplasia (15.4%), 512 of 784 with high‐grade squamous intraepithelial neoplasia (65.3%), 29 of 30 with squamous cell carcinoma (96.7%), 4 of 27 with atypical glandular cells (14.8%), and 85 of 21,454 with normal cytology results (0.4%). No invasive cancers were found to have atypical squamous cells, atypical glandular cells, or cytologically normal slides. The overall sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of LBC for detecting CIN2+ were 81.0%, 95.4%, 38.3%, 99.3 %, and 94.9%, respectively. Although Hybrid Capture 2 was more sensitive than LBC, the specificity, positive predictive value, and overall accuracy of LBC were higher than those of Hybrid Capture2 at 85.2%, 18.6%, and 85.5%, respectively. CONCLUSIONS The results of the current study indicate that the performance of LBC can effectively predict the risk of existing CIN2+ and may be a good screening tool for cervical cancer prevention in a developing country. Cancer (Cancer Cytopathol) 2013;121:473‐82. © 2013 American Cancer Society.Keywords
This publication has 34 references indexed in Scilit:
- Comparison of ThinPrep and SurePath liquid‐based cytology and subsequent human papillomavirus DNA testing in ChinaCancer Cytopathology, 2011
- Prevalence of HPV infection and cervical intraepithelial neoplasia and attitudes towards HPV vaccination among Chinese women aged 18–25 in Jiangsu ProvinceChinese Journal of Cancer Research, 2011
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialThe Lancet Oncology, 2010
- Use of an expanded gold standard to estimate the accuracy of colposcopy and visual inspection with acetic acidInternational Journal of Cancer, 2009
- A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural ChinaThe Lancet Oncology, 2008
- 2006 consensus guidelines for the management of women with abnormal cervical cancer screening testsAmerican Journal of Obstetrics and Gynecology, 2007
- Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trialBMJ, 2007
- Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based studyBritish Journal of Cancer, 2006
- Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worseAmerican Journal of Obstetrics and Gynecology, 2004
- Does Liquid-Based Technology Really Improve Detection of Cervical Neoplasia?Acta Cytologica, 2001